Literature DB >> 11922642

Combined effects of systolic blood pressure and serum cholesterol on cardiovascular mortality in young (<55 years) men and women.

F Thomas1, K Bean, L Guize, S Quentzel, P Argyriadis, A Benetos.   

Abstract

AIMS: To evaluate the combined effects of the two most frequent modifiable risk factors, systolic blood pressure and serum cholesterol, on cardiovascular and coronary mortality, in a large French population aged 18 to 55 years. METHODS AND
RESULTS: We studied 108,879 men (mean age 39.1+/-9.4 years) and 84,931 women (mean age 37.3+/-10.0 years) who had a health check-up at the IPC Center between 1978 and 1988. Mortality data for a mean period of 13 years were analysed. Systolic blood pressure and cholesterol levels were classified according to the cut-points proposed by international guidelines. In men, the prevalence of high cholesterol was more than twice as high in hypertensives as in normotensives; in women, it was more than three times higher. The combination of these two risk factors has additive effects on cardiovascular disease and coronary heart disease risk. In men, a borderline elevation of both systolic blood pressure (130-139 mmHg) and cholesterol (200-239 mg x dl(-1)) leads to a three- to four-fold increase in cardiovascular disease risk. Men with systolic blood pressure >or=160 mmHg represent a small percentage (about 5%) who have a 10-fold increase in cardiovascular disease and coronary heart disease risk, especially when high cholesterol is present. In women of the same age, similar trends were observed, but the results were less significant, probably due to the low cardiovascular disease mortality rates.
CONCLUSIONS: In conclusion, in French subjects under 55 years of age, a combination of high systolic blood pressure and high serum cholesterol dramatically increased cardiovascular disease and coronary heart disease risk, especially in men. A more aggressive public health policy is needed to prevent the development of risk factors in younger subjects. Copyright 2001 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2002        PMID: 11922642     DOI: 10.1053/euhj.2001.2888

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  35 in total

Review 1.  Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseases.

Authors:  Ehete Bahiru; Angharad N de Cates; Matthew Rb Farr; Morag C Jarvis; Mohan Palla; Karen Rees; Shah Ebrahim; Mark D Huffman
Journal:  Cochrane Database Syst Rev       Date:  2017-03-06

2.  Predictors of adherence to concomitant antihypertensive and lipid-lowering medications in older adults: a retrospective, cohort study.

Authors:  Richard H Chapman; Allison A Petrilla; Joshua S Benner; J Sanford Schwartz; Simon S K Tang
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

3.  Fixed-dose combination therapy for the prevention of cardiovascular disease.

Authors:  Angharad N de Cates; Matthew Rb Farr; Karen Rees; Juan P Casas; Mark Huffman
Journal:  Cochrane Database Syst Rev       Date:  2012

4.  Metabolomic signature of arterial stiffness in male patients with peripheral arterial disease.

Authors:  Maksim Zagura; Jaak Kals; Kalle Kilk; Martin Serg; Priit Kampus; Jaan Eha; Ursel Soomets; Mihkel Zilmer
Journal:  Hypertens Res       Date:  2015-07-02       Impact factor: 3.872

Review 5.  Combined antihypertensive and lipid-lowering treatment.

Authors:  Maurizio Cesari; Achille C Pessina
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

6.  Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees.

Authors:  Richard H Chapman; Jason Yeaw; Craig S Roberts
Journal:  BMC Cardiovasc Disord       Date:  2010-06-17       Impact factor: 2.298

7.  Clustering of vascular risk factors and in-hospital death after acute ischemic stroke.

Authors:  J Roquer; A Ois; A Rodríguez Campello; M Gomis; E Munteis; J Jiménez Conde; J E Martínez-Rodríguez
Journal:  J Neurol       Date:  2007-11-15       Impact factor: 4.849

8.  Influence of dyslipidemia in control of arterial hypertension among type-2 diabetics in the western region of the Republic of Macedonia.

Authors:  Ylber Jani; Amet Kamberi; Fatmir Ferati; Atila Rexhepi; Bekim Pocesta; Nikola Orovcanec; Dali Lala; Gafur Polisi; Mair Iseni; Arben Mirto; Agim Zeqiri
Journal:  Am J Cardiovasc Dis       Date:  2014-06-28

9.  Treatment intensification and risk factor control: toward more clinically relevant quality measures.

Authors:  Joseph V Selby; Connie S Uratsu; Bruce Fireman; Julie A Schmittdiel; Tiffany Peng; Nicolas Rodondi; Andrew J Karter; Eve A Kerr
Journal:  Med Care       Date:  2009-04       Impact factor: 2.983

10.  Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?

Authors:  Richard H Chapman; Elise M Pelletier; Paula J Smith; Craig S Roberts
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.